The table below is a review of notable updates that occurred in January 2026 for investigational products in development (not an inclusive list). Click on the status to view our full coverage.

HealthDay News — The US Food and Drug Administration (FDA) will now allow food labels to claim products have “no artificial colors” as long as they avoid petroleum-based dyes.

Breakthrough Therapy status for rilzabrutinib in wAIHA addresses the lack of approved treatments for this rare and life-threatening condition.

Decrease in male-to-female ratio seen with increasing age at diagnosis and by calendar period for those aged older than 10 years ...

Fewer interval cancers that were invasive, T2+, or non-luminal A were found in group with AI-supported mammography versus standard double reading ...

Another major medical group says most gender-related surgeries for minors in the US should be postponed until adulthood. The American Medical Association (AMA) said Wednesday that surgical ...

HealthDay News — For early-morning shift workers with shift work disorder (SWD), treatment with solriamfetol significantly improves sleepiness, according to a study published in the February issue of ...

HealthDay News — More than 31,000 nurses and health care workers walked off the job Monday morning at Kaiser Permanente ...

Yuvezzi, a combination cholinergic agonist and alpha-adrenergic agonist, is now FDA-approved as a once-daily treatment for ...

Vybrique is an oral film formulation of sildenafil, a phosphodiesterate-5 inhibitor, designed to dissolve on the tongue without the need for food or water.

Amgen is providing prescribers with updated information regarding Tavneos (avacopan) following a request from the FDA to remove the product from the market.

HealthDay News — A fast-growing measles outbreak in South Carolina has eclipsed last year’s record-setting Texas surge. As of ...